Alaklabi, S.; Maguire, O.; Pattnaik, H.; Zhang, Y.; Chow, J.; Wang, J.; Minderman, H.; Iyer, R.
Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Cancers 2024, 16, 3104.
https://doi.org/10.3390/cancers16173104
AMA Style
Alaklabi S, Maguire O, Pattnaik H, Zhang Y, Chow J, Wang J, Minderman H, Iyer R.
Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Cancers. 2024; 16(17):3104.
https://doi.org/10.3390/cancers16173104
Chicago/Turabian Style
Alaklabi, Sabah, Orla Maguire, Harsha Pattnaik, Yali Zhang, Jacky Chow, Jianmin Wang, Hans Minderman, and Renuka Iyer.
2024. "Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors" Cancers 16, no. 17: 3104.
https://doi.org/10.3390/cancers16173104
APA Style
Alaklabi, S., Maguire, O., Pattnaik, H., Zhang, Y., Chow, J., Wang, J., Minderman, H., & Iyer, R.
(2024). Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Cancers, 16(17), 3104.
https://doi.org/10.3390/cancers16173104